Package 50090-5334-0

Brand: bupropion hydrochloride (xl)

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 50090-5334-0
Digits Only 5009053340
Product NDC 50090-5334
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5334-0)

Marketing

Marketing Status
Marketed Since 2020-11-03
Brand bupropion hydrochloride (xl)
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (0)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c799e3b4-7b1b-440e-ad0a-02eee6a2d8df", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["ef8ef9ba-ab2a-4af9-ac11-12dd1b603a4a"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5334-0)", "package_ndc": "50090-5334-0", "marketing_start_date": "20201103"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5334-1)", "package_ndc": "50090-5334-1", "marketing_start_date": "20201103"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "50090-5334_c799e3b4-7b1b-440e-ad0a-02eee6a2d8df", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-5334", "generic_name": "bupropion hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA210081", "marketing_category": "ANDA", "marketing_start_date": "20180830", "listing_expiration_date": "20261231"}